200,000+ products from a single source!
sales@angenechem.com
            CAS No: 131060-14-5 Catalog No: AG000VGJ MDL No:MFCD00898838
| Title | Journal | 
|---|---|
| Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. | Journal of cellular physiology 20110901 | 
| Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. | Endocrinology 20081001 | 
| Synthesis and biological activity of a novel squalene epoxidase inhibitor, FR194738. | Bioorganic & medicinal chemistry letters 20040209 | 
| Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes. | Journal of lipid research 20030101 | 
| [Other antihyperlipidemic drugs with novel mechanism]. | Nihon rinsho. Japanese journal of clinical medicine 20010301 | 
| Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells: a new type of potent squalene epoxidase inhibitors. | Bioorganic & medicinal chemistry letters 19980602 | 
| (Aryloxy)methylsilane derivatives as new cholesterol biosynthesis inhibitors: synthesis and hypocholesterolemic activity of a new class of squalene epoxidase inhibitors. | Journal of medicinal chemistry 19950818 | 
© 2019 Angene International Limited. All rights Reserved.